SAFRAN (EPA:SAF) | WebDisclosure

Basculer en Français

9904	Companies
199560	Keywords
130432	Articles
106067	Press releases

Home
Companies
SAFRAN

REGULATED PRESS RELEASE

published on 10/09/2023 at 12:07, 2 years 4 months ago

Déclaration des transactions sur actions propres réalisées du 02/10/2023 au 06/10/2023
REGULATED PRESS RELEASE

published on 10/09/2023 at 12:07, 2 years 4 months ago

Statement of transactions in own shares from October 2, 2023 to October 6, 2023
REGULATED PRESS RELEASE

published on 10/02/2023 at 15:28, 2 years 4 months ago

Déclaration des transactions sur actions propres réalisées du 25/09/2023 au 29/09/2023
REGULATED PRESS RELEASE

published on 10/02/2023 at 15:28, 2 years 4 months ago

Statement of transactions in own shares from September 25, 2023 to September 29, 2023

Accesswire

Published on 02/21/2026 at 00:45, 1 day 12 hours ago

Bocana Resources Corp. Extends Letter of Intent on Arizona Mining Claims for Additional Bulk Testing and Assay Review
Published on 02/21/2026 at 00:30, 1 day 12 hours ago

Redwood AI Corp. Announces Engagement for IR Services
Published on 02/20/2026 at 23:15, 1 day 13 hours ago

DigiPower X Announces Closing of Settlement
Published on 02/20/2026 at 23:00, 1 day 13 hours ago

Infinico Metals Corp. Announces Effective Date for 15-for-1 Common Share Consolidation
Published on 02/20/2026 at 22:17, 1 day 14 hours ago

Organto Foods Completes Warrant Exercise Incentive Program

View all ACCESSWIRE

EQS Group

Published on 02/22/2026 at 12:19, 30 minutes ago

Elmos Semiconductor SE: Generational change initiated in the Supervisory Board
Published on 02/22/2026 at 10:09, 2 hours 40 minutes ago

Turkiye Garanti Bankasi A.S.: Regarding the Sale of Non-Performing Loans Portfolio
Published on 02/21/2026 at 12:00, 1 day ago

Abivax Presents First Evidence of Anti-Fibrotic Activity for Obefazimod Alongside New Clinical Efficacy and Safety Analyses in Inflammatory Bowel Disease at ECCO 2026
Published on 02/21/2026 at 12:00, 1 day ago

Abivax présente, au Congrès de l’ECCO 2026, les premières preuves d’une activité antifibrotique d'obefazimod, ainsi que de nouvelles analyses de son efficacité et de sécurité dans les MICI
Published on 02/20/2026 at 18:36, 1 day 18 hours ago

EQS-Adhoc: innoscripta SE: Management Board Proposes Dividend of EUR 4.00 per Share

Les Echos

Published on 02/20/2026 at 19:29, 1 day 17 hours ago

SFPI GROUP: Liquidity agreement report S2 2025
Published on 02/20/2026 at 19:29, 1 day 17 hours ago

SFPI GROUP: bilan du contrat de liquidité S2 S025
Published on 02/20/2026 at 18:00, 1 day 18 hours ago

TERACT - Termination of liquidity agreement
Published on 02/20/2026 at 18:00, 1 day 18 hours ago

TERACT - Résiliation du contrat de liquidité
Published on 02/20/2026 at 17:35, 1 day 19 hours ago

CHIFFRE D'AFFAIRES 2025

View all LES ECHOS COMFI WIRE